DSS
DSS, Inc.
There isn't enough reported data to score DSS yet.
LCID
Lucid Group, Inc.
LCID lost money over the past year, so it has no meaningful PE right now. Analysts expect losses to shrink, though they disagree widely on how much.
DSS Fundamentals
| Metric | Status |
|---|---|
| Weak | |
| Weak | |
| Weak | |
| Unavailable |
DSS's revenue, profitability and cash flow are currently weak. There isn't enough data to rate its balance sheet.
LCID Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
LCID's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
DSS PE Valuation
DSS has no meaningful PE right now: it lost money over the past year.
LCID PE Valuation
LCID has no meaningful PE right now: it lost money over the past year.
DSS Forward outlook
There aren't enough analyst estimates for DSS to show an outlook.
LCID Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect LCID's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
DSS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2025 | -$5.68 | -$2.09 |
| Q2 2025 | -$6.18 | -$2.74 |
| Q1 2025 | -$6.60 | +$1.58 |
| Q4 2024 | -$6.63 | +$2.17 |
| Q3 2024 | -$3.59 | +$8.07 |
| Q2 2024 | -$3.44 | +$10.40 |
| Q1 2024 | -$8.18 | +$1.19 |
| Q4 2023 | -$8.80 | +$1.23 |
LCID has the stronger earnings trend. Trailing diluted EPS is down 258% for DSS versus LCID down 224%.
LCID Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$13.08 | -$2.57 |
| Q2 2026 | -$13.65 | -$2.35 |
| Q1 2026 | -$13.15 | -$1.25 |
| Q4 2025 | -$12.09 | +$0.41 |
| Q3 2025 | -$10.51 | +$2.49 |
| Q2 2025 | -$11.30 | +$0.40 |
| Q1 2025 | -$11.90 | +$0.40 |
| Q4 2024 | -$12.50 | +$1.10 |
LCID is still losing money, but less than at its worst: $13.08 per share over the past year, against $16.50 at its worst in mid-2023.
DSS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $3.6M | -32% |
| Q1 2026 | $4.3M | -13% |
| Q4 2025 | $4.1M | -24% |
| Q3 2025 | $6.4M | +14% |
| Q2 2025 | $5.3M | +26% |
| Q1 2025 | $5M | +28% |
| Q4 2024 | $5.4M | +101% |
| Q3 2024 | $5.6M | +34% |
DSS's revenue has slid since its 2022 peak: $4M last quarter, down 32% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -105% | -40 points |
| Q1 2026 | -127% | -52 points |
| Q4 2025 | -98% | +425 points |
| Q3 2025 | -51% | +33 points |
| Q2 2025 | -65% | +52 points |
| Q1 2025 | -75% | +46 points |
| Q4 2024 | -523% | -427 points |
| Q3 2024 | -83% | +39 points |
DSS has the edge over LCID on profitability, with a higher operating margin.
LCID Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $350.3M | +4.1% |
| Q2 2026 | $405.3M | +56% |
| Q1 2026 | $282.5M | +20% |
| Q4 2025 | $522.7M | +123% |
| Q3 2025 | $336.6M | +68% |
| Q2 2025 | $259.4M | +29% |
| Q1 2025 | $235M | +36% |
| Q4 2024 | $234.5M | +49% |
LCID has the edge over DSS on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -245% | +35 points |
| Q2 2026 | -267% | +43 points |
| Q1 2026 | -350% | -56 points |
| Q4 2025 | -204% | +109 points |
| Q3 2025 | -280% | +105 points |
| Q2 2025 | -310% | +83 points |
| Q1 2025 | -294% | +128 points |
| Q4 2024 | -313% | +156 points |
LCID's operating margin was −245% last quarter, up 35 points from the same quarter a year ago, near the top of its range since 2020.
DSS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$1.9M | -195% |
| Q1 2026 | -$330K | +$1.4M |
| Q4 2025 | -$1.6M | -$1.6M |
| Q3 2025 | -$8.1M | -$4.5M |
| Q2 2025 | $2M | +$5.4M |
| Q1 2025 | -$1.7M | +$463K |
| Q4 2024 | -$5K | -100% |
| Q3 2024 | -$3.6M | -$2.2M |
DSS has the edge over LCID on cash flow, with more consistent year-over-year improvement.
LCID Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1B | -$84.2M |
| Q2 2026 | -$1.5B | -$463.2M |
| Q1 2026 | -$1.4B | -$849M |
| Q4 2025 | -$1.2B | -$417.1M |
| Q3 2025 | -$955.5M | -$333M |
| Q2 2025 | -$1B | -$271.6M |
| Q1 2025 | -$589.9M | +$125.1M |
| Q4 2024 | -$824.8M | -$77.6M |
LCID has burned cash in almost every quarter: −$5.2B over the past year, against −$3.4B the year before.
DSS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +4.1% | +393K shares |
| 1 year | +10% | +950K shares |
| 3 years | +44% | +3.1M shares |
| 5 years | +2289% | +9.6M shares |
DSS has the edge over LCID on shareholder dilution, with a more favorable share count trend.
LCID Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.3% | +12.5M shares |
| 1 year | +26% | +82.4M shares |
| 3 years | +73% | +166M shares |
LCID has 395M diluted shares, up 26% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | $2.2M |
| Q1 2020 | — |
DSS Net Leverage
DSS's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
LCID Net Leverage
LCID's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
DSS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 41.6 | Neutral |
| Stochastic | 7.2 | Oversold |
DSS's weekly RSI is 42 (neutral) and its Stochastic is 7 (oversold).
LCID Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.9 | Neutral |
| Stochastic | 7.1 | Oversold |
LCID's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
DSS PE vs Consumer Cyclical Sector
DSS has no meaningful PE right now: it lost money over the past year.
LCID PE vs Consumer Cyclical Sector
LCID has no meaningful PE right now: it lost money over the past year.
DSS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $0.57 | 8.8% below |
| 20 week MA | $0.59 | 12% below |
| 50 week MA | $0.73 | 29% below |
| 100 week MA | $0.87 | 40% below |
| 200 week MA | $1.86 | 72% below |
DSS is in a downtrend: it's below all five of its weekly moving averages, and 72% below its 200-week average.
LCID Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.53 | 7.9% below |
| 20 week MA | $4.88 | 33% below |
| 50 week MA | $7.33 | 56% below |
| 100 week MA | $15.4 | 79% below |
| 200 week MA | $31.9 | 90% below |
LCID is in a downtrend: it's below all five of its weekly moving averages, and 90% below its 200-week average.
DSS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $160.5 | $118.3 | -26% |
| 2021 | $118.3 | $14.5 | -88% |
| 2022 | $14.5 | $3.44 | -76% |
| 2023 | $3.44 | $2.40 | -30% |
| 2024 | $2.40 | $0.90 | -63% |
| 2025 | $0.90 | $0.97 | +7.8% |
| 2026 YTD | $0.97 | $0.52 | -46% |
DSS has the edge over LCID on returns for 2026, with the stronger performance.
LCID Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $98.9 | $100.4 | +1.5% |
| 2021 | $100.4 | $376.4 | +275% |
| 2022 | $376.4 | $67.0 | -82% |
| 2023 | $67.0 | $42.1 | -37% |
| 2024 | $42.1 | $32.0 | -24% |
| 2025 | $32.0 | $11.4 | -64% |
| 2026 YTD | $11.4 | $3.25 | -72% |
LCID has finished four years in a row lower, and it's down 72% so far in 2026.